Our SQLM site in Normandy, France, has a new operations facility opened in 2013 and the Vemula state-of- the-art plant in India was completed in February 2018, with new furnaces, each with ISO 8 cleanrooms (1700m 2 and 2400 m 2 ) Together these plants offer 31,800m 2 and 11,000m 2 , yielding a production capacity of 1.5 million vials and ampoules daily from SQLM and 1 million vials a day from Vemula. This, together with our ex-stock capacity, allows us to meet the vaccine demand while still servicing our other customers.
- About us
- News
- Careers
- Products & Innovations
- Ampoules
- Vials Type I
- Injectable vials
- Infusions
- Oral
- Nasal
- Healthcare
- Beauty & Care
- SGD Pharma Plus
- Media center
- Contact us